Therefore, the present study was performed to explore the associations between the expression of syntenin in patients with lung cancer and their clinicopathological characteristics and prognosis, and to analyze the expression level of serum syntenin and its correlation with VEGF expression level in patients with lung cancer. This evidence concerns the gene SDCBP and lung carcinoma.